Literature DB >> 2755576

Coagulation and fibrinolysis in chronic subdural hematoma.

Y Kawakami1, M Chikama, T Tamiya, Y Shimamura.   

Abstract

In 19 patients with chronic subdural hematoma, coagulation and fibrinolysis in venous blood taken at the time of surgery and in the hematoma contents aspirated from chronic subdural hematoma were studied. Compared with coagulation results for venous blood, the hematoma contents demonstrated marked prolongation of the recalcification time, prothrombin time, and activated partial thromboplastin time, and marked reduction of clotting factor V, the hepaplastin test, prothrombin, and fibrinogen. Antithrombin III was also decreased, and fibrinopeptide A was increased in the hematomas. Fibrinolytic results demonstrated that both plasminogen and alpha 2-plasmin inhibitor were decreased, and both fibrinopeptide B beta 15-42 and fibrin and fibrinogen degradation products were increased in the hematomas. These findings indicate excessive activation of the clotting system, thrombin generation, and increased fibrinolytic activity occurring in the hematomas. From these results, excessive activation of both the clotting and fibrinolytic systems is emphasized to be the possible etiological factor for the origin and development of chronic subdural hematoma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2755576     DOI: 10.1097/00006123-198907000-00005

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  14 in total

1.  Outcome of contemporary surgery for chronic subdural haematoma: evidence based review.

Authors:  R Weigel; P Schmiedek; J K Krauss
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

2.  Response to Comment on"Massive spontaneous parasellar and retroclival subdural hematoma".

Authors:  Zongli Han; Yanli Du; Hui Qi
Journal:  Neuroradiology       Date:  2017-03-14       Impact factor: 2.804

3.  Spontaneous chronic subdural hematoma in young adult: the role of missing coagulation facto.

Authors:  M Dobran; M Iacoangeli; A R Scortichini; F Mancini; R Benigni; D Nasi; M Gladi; M Scerrati
Journal:  G Chir       Date:  2017 Mar-Apr

4.  Fibrin glue injection into the hematoma cavity for refractory chronic subdural hematoma: A case report.

Authors:  Saiko Watanabe; Kenichi Amagasaki; Naoyuki Shono; Hiroshi Nakaguchi
Journal:  Surg Neurol Int       Date:  2016-11-21

5.  Subdural hematoma caused by epithelioid angiosarcoma originating from the skull.

Authors:  Yasuhiro Yamada; Joji Inamasu; Shigeta Moriya; Daikichi Oguri; Mitsuhiro Hasegawa; Masato Abe; Yuichi Hirose
Journal:  Head Neck Pathol       Date:  2012-07-29

6.  Chronic subdural hematoma outcome prediction using logistic regression and an artificial neural network.

Authors:  Mehdi Abouzari; Armin Rashidi; Mehdi Zandi-Toghani; Mehrdad Behzadi; Marjan Asadollahi
Journal:  Neurosurg Rev       Date:  2009-08-04       Impact factor: 3.042

7.  Kallikrein-kinin system in chronic subdural haematomas: its roles in vascular permeability and regulation of fibrinolysis and coagulation.

Authors:  H Fujisawa; H Ito; S Kashiwagi; S Nomura; M Toyosawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

Review 8.  Organized intrasylvian subarachnoid hematoma in post-traumatic child with dyskinesia for 8 years: a case report and review of the literature.

Authors:  Yang Zhao; Hui-ming Jin; Lian-ping Sun; Feng Jiang; Ting Zhang; Jie Ma
Journal:  Childs Nerv Syst       Date:  2009-03-24       Impact factor: 1.475

9.  Magnetic resonance imaging findings predict the recurrence of chronic subdural hematoma.

Authors:  Haruo Goto; Osamu Ishikawa; Masashi Nomura; Kentaro Tanaka; Seiji Nomura; Keiichiro Maeda
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-01-23       Impact factor: 1.742

10.  Intracerebral hemorrhage following evacuation of a chronic subdural hematoma.

Authors:  Jong Kyu Kim; Seok Won Kim; Sung Hoon Kim
Journal:  J Korean Neurosurg Soc       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.